Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer [Phase 1]
A Biogen-sponsored Phase 1 study evaluating gemcitabine with RTA 402 (bardoxolone methyl) in patients with unresectable pancreatic cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating surufatinib in combination with TAS-102 for advanced pancreatic cancer in third-line and beyond has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer [Phase 3]
Phase 3 trial assessing intraoperative celiac plexus neurolysis in patients with operable pancreatic and periampullary cancer; study status …
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study [NA]
The RT-CAMSS study, a real-time monitoring trial of chemotherapy side-effects in gastrointestinal cancers, has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer [Phase 2]
An ongoing Phase 2 clinical trial is evaluating cadonilimab in combination with S-1 or capecitabine as second-line therapy for advanced panc…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy [Phase 2]
A Phase 2 trial evaluating endoscopic botulinum toxin injection to prevent postoperative pancreatic fistula after distal pancreatectomy was …
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: tislelizUMaB in canceR Patients With molEcuLar residuaL Disease [Phase 3]
Phase 3 trial evaluating tislelizumab in cancer patients with molecular residual disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Multimodal Managements for Metastatic Pancreatic Cancer.
A completed clinical trial evaluating multimodal management strategies for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Statin Addition to Chemotherapy for Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating adding a statin to chemotherapy for advanced pancreatic cancer has completed; the snippet does not report results…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 study (QUILT-3.010) evaluating gemcitabine and nab-paclitaxel with or without NPC-1C in pancreatic cancer has been terminated; r…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Whipple Protein Study [NA]
A clinical trial (NCT04306874) studying a Whipple Protein for pancreatic cancer and malnutrition has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of L-DOS47 plus doxorubicin in advanced pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy [Phase 2]
Phase 2 trial evaluating the effect of proton pump inhibitors on postoperative recovery after pancreaticoduodenectomy; the study was termina…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer [NA]
A completed clinical trial evaluating the feasibility of a healthcare-provider-guided exercise program before surgical resection in patients…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Fatigue and Pancreas and Bile Duct Cancer Study [EARLY_Phase 1]
An early-phase Phase 1 clinical trial studying fatigue in pancreatic cancer and cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating intravenous vitamin C in combination with standard chemotherapy for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 [Phase 2]
Phase 2 trial of ponsegromab in cancer patients with cachexia and elevated GDF-15 completed; results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study of Irinotecan Liposome in Advanced Pancreatic Cancer [Phase 1]
A Phase 1 study of irinotecan liposome in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)
This update reports the completion of a clinical validation study for Immunovia's VERIFI blood biomarker test intended to detect early-stage…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer
This completed clinical trial validates Immunovia's next-generation blood biomarker test for detecting pancreatic cancer at early stages.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: SENECA: First Line metaStatic pancrEatic caNcer Primary and Distant (if Oligometastatic) lEsion direCted rAdiotherapy [Phase 3]
Phase 3 SENECA trial evaluates first-line metastasis-directed radiotherapy (including primary and distant lesions in oligometastatic pancrea…